Aberdeen Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Aberdeen Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.6K	Sell	119 -804	-87%	-$451K	0.03%	201
2026 Q1	$519K	Sell	923 -35	-4%	-$22.4K	0.24%	87
2025 Q4	$648K	Sell	958 -50	-5%	-$34.1K	0.3%	72
2025 Q3	$644K	Hold	1,008	–	–	0.4%	73
2025 Q2	$541K	Hold	1,008	–	–	0.36%	79
2025 Q1	$423K	Hold	1,008	–	–	0.29%	94
2024 Q4	$417K	Hold	1,008	–	–	0.29%	96
2024 Q3	$509K	Hold	1,008	–	–	0.34%	90
2024 Q2	$491K	Hold	1,008	–	–	0.33%	87
2024 Q1	$544K	Sell	1,008 -10	-1%	-$5.46K	0.32%	85
2023 Q4	$565K	Hold	1,018	–	–	0.41%	74
2023 Q3	$445K	Hold	1,018	–	–	0.34%	81
2023 Q2	$511K	Sell	1,018 -50	-5%	-$24K	0.37%	76
2023 Q1	$534K	Sell	1,068 -20	-2%	-$9.57K	0.4%	71
2022 Q4	$444K	Hold	1,088	–	–	0.33%	85
2022 Q3	$354K	Hold	1,088	–	–	0.31%	93
2022 Q2	$382K	Hold	1,088	–	–	0.3%	89
2022 Q1	$595K	Hold	1,088	–	–	0.41%	71
2021 Q4	$716K	Sell	1,088 -50	-4%	-$31.4K	0.47%	62
2021 Q3	$708K	Sell	1,138 -130	-10%	-$87.4K	0.69%	50
2021 Q2	$801K	Hold	1,268	–	–	0.74%	45
2021 Q1	$620K	Sell	1,268 -131	-9%	-$65.6K	0.49%	57
2020 Q4	$699K	Buy	1,399 +11	+0.8%	+$4.92K	0.53%	57
2020 Q3	$546K	Sell	1,388 -720	-34%	-$266K	0.52%	55
2020 Q2	$696K	Buy	2,108 +450	+27%	+$130K	0.75%	44
2020 Q1	$402K	Hold	1,658	–	–	0.49%	63
2019 Q4	$433K	Buy	+1,658	New	+$437K	0.32%	78

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Aberdeen Wealth Management's IDXX Position: Q2 2026 in Review

Aberdeen Wealth Management reduced its Idexx Laboratories (IDXX) stake by 87% in Q2 2026, selling an estimated $451K and leaving 119 shares worth $62.6K. The position accounts for 0.03% of the portfolio, ranked #201.

Aberdeen Wealth Management first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $801K in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Aberdeen Wealth Management held 119 shares of Idexx Laboratories worth $62.6K as of Q2 2026.
Aberdeen Wealth Management sold 804 Idexx Laboratories shares in Q2 2026, an estimated $451K.
Idexx Laboratories made up 0.03% of Aberdeen Wealth Management's portfolio in Q2 2026, its #201 holding.
Aberdeen Wealth Management first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
Aberdeen Wealth Management's Idexx Laboratories position peaked at $801K in Q2 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.